Paul Emery Selected Research

Methotrexate (Mexate)

1/2022	Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach.
1/2021	Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission.
11/2020	Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis.
1/2020	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
1/2020	Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity.
6/2019	Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial.
1/2019	Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study.
1/2019	Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
1/2019	Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study.
12/2018	On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Emery Research Topics

Disease

263	Rheumatoid Arthritis 06/2022 - 02/2002
41	Synovitis 01/2022 - 03/2002
39	Necrosis 11/2020 - 01/2004
38	Arthritis (Polyarthritis) 01/2022 - 08/2002
37	Inflammation (Inflammations) 01/2022 - 02/2002
21	Infections 10/2020 - 06/2004
20	Pain (Aches) 01/2022 - 03/2007
20	Rheumatic Diseases (Rheumatism) 01/2019 - 12/2003
19	Ankylosing Spondylitis 11/2021 - 01/2003
17	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2022 - 10/2003
17	Psoriatic Arthritis 01/2022 - 02/2003
15	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 01/2004
12	Fatigue 09/2019 - 09/2006
7	Edema (Dropsy) 01/2022 - 02/2002
7	Osteitis 01/2021 - 11/2011
6	Arthralgia (Joint Pain) 01/2022 - 10/2006
6	Fibrosis (Cirrhosis) 12/2021 - 11/2013
6	Neoplasms (Cancer) 03/2020 - 01/2005
6	Chronic Disease (Chronic Diseases) 09/2019 - 02/2002
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 06/2007
6	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 11/2002
6	Disease Progression 01/2018 - 01/2003
6	Osteoarthritis 07/2013 - 08/2002
5	Skin Diseases (Skin Disease) 01/2020 - 05/2008
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2013 - 05/2009
4	Body Weight (Weight, Body) 12/2015 - 11/2003
3	Tenosynovitis 11/2021 - 10/2007
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 08/2013
3	Neutropenia 11/2019 - 12/2015
3	Periodontal Diseases (Periodontal Disease) 01/2019 - 09/2015
3	Hypertension (High Blood Pressure) 01/2018 - 03/2007
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2017 - 11/2002
3	Joint Diseases (Joint Disease) 02/2014 - 01/2008
2	Axial Spondyloarthritis 07/2022 - 09/2013

Drug/Important Bio-Agent (IBA)

81	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2002
50	Antirheumatic Agents (DMARD)IBA 07/2022 - 11/2003
49	Rituximab (Mabthera)FDA Link 01/2021 - 06/2004
44	Biological ProductsIBA 07/2022 - 08/2005
32	Etanercept (Enbrel)FDA Link 01/2021 - 01/2004
31	Abatacept (Orencia)FDA Link 01/2022 - 06/2002
28	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 07/2002
27	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2003
25	Infliximab (Remicade)FDA Link 01/2020 - 01/2004
24	Tumor Necrosis Factor InhibitorsIBA 11/2021 - 01/2003
23	AutoantibodiesIBA 01/2022 - 10/2003
23	Adalimumab (Humira)FDA Link 01/2020 - 01/2003
16	Pharmaceutical PreparationsIBA 01/2022 - 10/2003
16	golimumab FDA Link 01/2020 - 08/2009
15	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 09/2010
15	tocilizumab (atlizumab)FDA Link 11/2020 - 12/2007
14	CytokinesIBA 03/2021 - 03/2004
14	Monoclonal AntibodiesIBA 01/2019 - 11/2004
13	baricitinibIBA 01/2021 - 01/2017
13	C-Reactive ProteinIBA 01/2019 - 11/2003
12	Certolizumab Pegol FDA Link 01/2020 - 11/2008
11	ametantrone (HAQ)IBA 01/2022 - 09/2006
11	Biosimilar PharmaceuticalsIBA 01/2021 - 03/2014
11	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 02/2002
11	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2012
11	Rheumatoid FactorIBA 01/2018 - 11/2003
9	AntibodiesIBA 08/2022 - 12/2015
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2003
8	GlucocorticoidsIBA 11/2021 - 05/2006
8	secukinumabIBA 01/2019 - 11/2013
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016 - 03/2002
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2014 - 08/2002
6	Peptides (Polypeptides)IBA 01/2021 - 10/2012
6	cyclic citrullinated peptideIBA 01/2021 - 09/2009
5	EpitopesIBA 01/2022 - 05/2008
5	Methylprednisolone FDA LinkGeneric 11/2021 - 11/2002
5	Interleukin-7 (Interleukin 7)IBA 03/2021 - 01/2005
5	Janus Kinase InhibitorsIBA 01/2021 - 06/2017
5	Immunoglobulin G (IgG)IBA 10/2020 - 12/2007
5	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2004
5	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 12/2006
5	amsonic acid (DAS)IBA 03/2019 - 12/2003
5	Interleukin-17 (Interleukin 17)IBA 01/2018 - 11/2013
5	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2013 - 02/2002
5	GadoliniumIBA 08/2009 - 02/2002
4	Janus KinasesIBA 01/2021 - 06/2017
4	InterferonsIBA 01/2021 - 01/2016
4	sarilumabIBA 11/2020 - 06/2017
4	EnzymesIBA 07/2020 - 06/2004
4	Immunoglobulins (Immunoglobulin)IBA 08/2015 - 12/2007
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2013 - 12/2007
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 09/2015
3	Interferon Type IIBA 12/2020 - 10/2017
3	upadacitinibIBA 01/2020 - 12/2016
3	AutoantigensIBA 11/2017 - 07/2013
3	Prednisolone (Predate)FDA LinkGeneric 12/2012 - 12/2006
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2010 - 05/2008
3	SteroidsIBA 02/2008 - 01/2004

Therapy/Procedure

100	Therapeutics 06/2022 - 02/2002
9	Biological Therapy 01/2018 - 01/2007
7	Aftercare (After-Treatment) 01/2019 - 02/2007
4	Drug Therapy (Chemotherapy) 07/2012 - 01/2004
3	Retreatment 01/2021 - 12/2011
3	Drug Tapering 01/2020 - 01/2018
3	Remission Induction 08/2013 - 01/2005
3	Injections 01/2011 - 01/2004